Avalyn aims for $182M IPO to fund phase 3 trials of reformulated respiratory drugs Read more →
Regeneron ushers in new genetic medicine era with groundbreaking gene therapy approval Read more →
Despite data concerns, Roche’s oral SERD can still be largest product in company history: exec Read more →